2vci
4,5 DIARYL ISOXAZOLE HSP90 CHAPERONE INHIBITORS: POTENTIAL THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER4,5 DIARYL ISOXAZOLE HSP90 CHAPERONE INHIBITORS: POTENTIAL THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER
Template:ABSTRACT PUBMED 18020435
About this StructureAbout this Structure
2vci is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Brough PA, Aherne W, Barril X, Borgognoni J, Boxall K, Cansfield JE, Cheung KM, Collins I, Davies NG, Drysdale MJ, Dymock B, Eccles SA, Finch H, Fink A, Hayes A, Howes R, Hubbard RE, James K, Jordan AM, Lockie A, Martins V, Massey A, Matthews TP, McDonald E, Northfield CJ, Pearl LH, Prodromou C, Ray S, Raynaud FI, Roughley SD, Sharp SY, Surgenor A, Walmsley DL, Webb P, Wood M, Workman P, Wright L. 4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer. J Med Chem. 2008 Jan 24;51(2):196-218. Epub 2007 Nov 20. PMID:18020435 doi:10.1021/jm701018h
Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)
OCACategories:
- Pages with broken file links
- Homo sapiens
- Aherne, W.
- Barril, X.
- Borgognoni, J.
- Boxal, K.
- Brough, P A.
- Cansfield, J E.
- Cheung, K M.
- Collins, I.
- Davies, N G.M.
- Drysdale, M J.
- Dymock, B.
- Eccles, S A.
- Finch, H.
- Fink, A.
- Hayes, A.
- Howes, R.
- Hubbard, R E.
- James, K.
- Jordan, A M.
- Lockie, A.
- Martins, V.
- Massey, A.
- Matthews, T P.
- Mcdonald, E.
- Northfield, C J.
- Pearl, L H.
- Prodromou, C.
- Ray, S.
- Raynaud, F I.
- Roughley, S D.
- Sharp, S Y.
- Surgenor, A.
- Walmsley, D L.
- Webb, P.
- Wood, M.
- Workman, P.
- Wright, L.
- Atp-binding
- Chaperone
- Nucleotide-binding
- Phosphorylation
- Stress response